Can Lexington Have It Both Ways?
After offering an incentive to lab developers by raising building heights, the town of Lexington is challenging them to deliver buildings equipped with some of the suburbs’ most energy-efficient building systems.
After offering an incentive to lab developers by raising building heights, the town of Lexington is challenging them to deliver buildings equipped with some of the suburbs’ most energy-efficient building systems.
A New York developer that owned an Assembly Square commercial property for decades says it was shortchanged by $22 million on the 2018 sale of a life science development site acquired this year by BioMed Realty for nearly $200 million.
BioMed Realty’s appetite for life science sites in Boston continues with the pending acquisition of a speculative office building nearing completion in South End.
BioMed Realty plans to develop 1.3 million square feet of office, lab and retail space at a newly-acquired development site in Somerville’s Assembly Square.
BioMed Realty has completed its $163 million acquisition of a development site in Somerville’s expanding Assembly Square commercial cluster, with plans for 1.3 million square feet of office, lab and retail space.
Berkeley Investments has begun a 300,000-square-foot speculative redevelopment in Malden Center, where it’s marketing space at the former bank data center to office and R&D tenants.
A Harvard University life science spinout is expanding from Cambridge to a Watertown property that was converted into office and lab space before being acquired by BioMed Realty last fall for $62.5 million.
Imagine if you spent $15 million on a swimming pool and your new neighbors started dropping by every day for a dip.
A partnership including Boston-based Cresset Group and Novaya Ventures has acquired a 9-acre property in Somerville’s Assembly Square, where the previous owner proposed a 1.9-million-square-foot mixed-use development.